Abstract

ObjectivesTo evaluate the 1 year clinical outcomes of remission steered therapy in early arthritis, initially with methotrexate (MTX) and a tapered high dose of prednisone, in case of remission followed...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
Cornelia F Allaart ... Lotte Heimans
Arthritis research & therapy | VOL. 18
Cornelia F Allaart, et. al.Cornelia F Allaart ... Lotte Heimans
21 Jan 2016
A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study
I Speyer ... T W J Huizinga
Annals of the Rheumatic Diseases | VOL. 73
I Speyer, et. al.I Speyer ... T W J Huizinga
28 May 2013
Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study
Kk Koudijs ... Kirsten Vc Boer
Arthritis Research & Therapy | VOL. 15
Kk Koudijs, et. al.Kk Koudijs ... Kirsten Vc Boer
01 Jan 2013
Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
Bernard A M Grillet ... Leroy R Lard
Annals of the rheumatic diseases | VOL. 77
Bernard A M Grillet, et. al.Bernard A M Grillet ... Leroy R Lard
28 Sep 2017
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers